Select a medication above to begin.
Troriluzole
troriluzole
Adult Dosing .
Dosage forms: CAP
Investigational New Drug (IND)
- [pending FDA approval]
spinocerebellar ataxia
- [indication/pt population pending FDA approval]
- Info: exact mechanism of action unknown; inhibits glutamate release; inactivates voltage-dependent sodium channels; interferes with intracellular events following excitatory amino acid receptor binding
Peds Dosing .
- Dosage forms: --
Investigational New Drug (IND)
- [pending FDA approval]
- Info: not anticipated to be applicable to Peds population